- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04901247
A Time-lapse Monitoring Prospective Study
Exploring Single Step Culture Medium Refreshment Effect on Embryo Ploidy Rate: A Time-lapse Monitoring Prospective Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The use of extended embryo culture to the blastocyst stage and PGT-A has enabled identification and selection of embryos with the best developmental potential and improved IVF clinical outcomes. It is considered a routine practice to grade the embryos on day 3 of development, which will require disturbing the culture conditions by annotating the embryos using inverted microscopes. However, the application of Time-lapse technology (TLS) allows annotating the embryos on day 3 without interrupting the culture conditions, especially if TLS is combined with single-step culture medium.
There are several culture factors that can affect embryo development, such as the pH, which is controlled through the concentration of CO2, and also the osmolality, which is the concentration of solute per liter of solution. Evaporation of the solution due to the exposure to high temperature (37°C) can change the concentrations and hence compromise embryo development.
Since single-step medium is designed to sustain embryo development for 5 continuous culture days, while some laboratories culture embryos for 7 days, refreshing the culture medium is inevitable either on day 3 or day 5 of development.
There is no concrete evidence on which of these practices will provide a better environment for embryo development. Moreover, none of the studies investigated the effect of single-step culture medium changeover on day 3 or day 5, on the chromosomal errors (aneuploidy). We aim in this study to explore which day of culture medium refreshment (day 3 or day 5) provides a higher rate of euploid blastocysts.
Summary about data collected. Categorical data will be presented in frequency tables and histograms. Continuous values will be summarized according the mean, standard deviation and confidence interval.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: BARBARA LAWRENZ, PhD
- Phone Number: 1108 97126528000
- Email: shieryl.digma@artfertilityclinics.com
Study Contact Backup
- Name: SHIERYL DIGMA, RN
- Phone Number: 1061 97126528000
- Email: shieryl.digma@artfertilityclinics.com
Study Locations
-
-
-
Abu Dhabi, United Arab Emirates
- ART Fertility Clinics
-
Abu Dhabi, United Arab Emirates
- Ibrahim Elkhatib
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with a minimum of 8 - 10 follicles during ovarian stimulation
- Patients with a minimum of 8 mature oocytes
- PGT-A
- ICSI
- BMI<35
- Age 18- 40
- Fresh or frozen ejaculatory sperm >10,000 motile sperm
- Any Ovarian stimulation
- Embryos cultured in Time-lapse system
Exclusion Criteria:
- PGT-M or PGT-SR
- Previous history of embryo arrest
- Endometriosis
- Hydrosalpinx
- History of uterine abnormality or previous uterine surgery
- History of previous treatment which may impact the ovarian reserve (adnexal surgery, chemotherapy, radiation…)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
day 3
embryo grading and culture refreshment will be done 67-69 hours post insemination
|
20µL of culture medium is aspirated using Eppendorf PCR tips, and freshly, overnight equilibrated 20µL global total LP will be added to the same well
embryo grading should be done prior to media refreshment
|
day 5
embryo grading and culture medium refreshment will be done 114-118 hours post insemination
|
20µL of culture medium is aspirated using Eppendorf PCR tips, and freshly, overnight equilibrated 20µL global total LP will be added to the same well
embryo grading should be done prior to media refreshment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
blastocyst ploidy
Time Frame: 3 days
|
determined after biopsy of trophectoderm cells, taken from the blastocyst on day 5, 6 or 7 from development.
|
3 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cycle ploidy rate
Time Frame: 1 day
|
the number of euploid embryos in the group divided by the total number of 2PN
|
1 day
|
mosaicism frequency
Time Frame: 1 day
|
defined as the rate of mosaic errors in aneuploid embryos.
This includes full mosaic embryos or aneuploid embryos with 1 or more mosaic chromosome aberration
|
1 day
|
blastocyst quality at time of biopsy
Time Frame: 1 day
|
Four Embryo Quality Scores (EQ1, 2, 3, 4) based on the expansion stage of the blastocyst, the grade of the inner cell mass and the grade of the trophectoderm
|
1 day
|
blastulation rate
Time Frame: 5 days
|
ability of the embryo to form a cavity (=to blastulate) 118hours post ICSI.
Number of blastocysts divided by the number of 2PN
|
5 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: IBRAHIM ELKHATIB, ART Fertility Clinics LLC
Publications and helpful links
General Publications
- Bavister BD, Poole KA. Duration and temperature of culture medium equilibration affect frequency of blastocyst development. Reprod Biomed Online. 2005 Jan;10(1):124-9. doi: 10.1016/s1472-6483(10)60813-9.
- Costa-Borges N, Belles M, Meseguer M, Galliano D, Ballesteros A, Calderon G. Blastocyst development in single medium with or without renewal on day 3: a prospective cohort study on sibling donor oocytes in a time-lapse incubator. Fertil Steril. 2016 Mar;105(3):707-713. doi: 10.1016/j.fertnstert.2015.11.038. Epub 2015 Dec 12.
- Krasnopolskaya KV, Beketova AN, Sesina NI, capital ES, Cyrillichinchenko NK, Badalyan GV, Sudarikova NM, Bocharova TV, Zakharchenko EO. The effect of short-term disturbance of day 3 embryo culture on the development and implantation. Gynecol Endocrinol. 2019;35(sup1):1-4. doi: 10.1080/09513590.2019.1632083.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2103-ABU-003-IK
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on media refreshment
-
ART Fertility Clinics LLCRecruiting
-
Unity Health TorontoCanadian Institutes of Health Research (CIHR); Applied Health Research CentreUnknownColorectal Cancer | Cancer Screening
-
Ganin Fertility CenterUnknownInfertility | Mosaicism | Aneuploidy RateEgypt
-
University Medical Centre LjubljanaUniversity of Ljubljana School of Medicine, SloveniaCompleted
-
Weill Medical College of Cornell UniversityVitrolifeTerminatedInfertilityUnited States
-
Coloplast A/SCompletedCatheter Site Discomfort | Catheter Site PainDenmark
-
Maria Fertility HospitalCompletedInfertilityKorea, Republic of
-
Amira MohamedCompletedOffice HysteroscopyEgypt
-
Innovation Research & TrainingCompletedSexual BehaviorUnited States